| Graft-versus-host disease JLM Ferrara, JE Levine, P Reddy, E Holler The Lancet 373 (9674), 1550-1561, 2009 | 3137 | 2009 |
| Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ... New England Journal of Medicine 379 (2), 111-121, 2018 | 2210 | 2018 |
| Prospective validation of a 21-gene expression assay in breast cancer JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ... New England Journal of Medicine 373 (21), 2005-2014, 2015 | 1553 | 2015 |
| Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease ND Mathewson, R Jenq, AV Mathew, M Koenigsknecht, A Hanash, ... Nature immunology 17 (5), 505-513, 2016 | 689 | 2016 |
| Acute graft-versus-host disease does not require alloantigen expression on host epithelium T Teshima, R Ordemann, P Reddy, S Gagin, C Liu, KR Cooke, ... Nature medicine 8 (6), 575-581, 2002 | 687 | 2002 |
| Pathophysiology of graft-versus-host disease JLM Ferrara, P Reddy Seminars in hematology 43 (1), 3-10, 2006 | 604 | 2006 |
| First-line nivolumab plus ipilimumab in advanced non–small-cell lung cancer (CheckMate 568): outcomes by programmed death ligand 1 and tumor mutational burden as biomarkers N Ready, MD Hellmann, MM Awad, GA Otterson, M Gutierrez, JF Gainor, ... Journal of Clinical Oncology 37 (12), 992-1000, 2019 | 568 | 2019 |
| Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer JA Sparano, RJ Gray, PM Ravdin, DF Makower, KI Pritchard, KS Albain, ... New England journal of medicine 380 (25), 2395-2405, 2019 | 480 | 2019 |
| A biomarker panel for acute graft-versus-host disease S Paczesny, OI Krijanovski, TM Braun, SW Choi, SG Clouthier, R Kuick, ... Blood, The Journal of the American Society of Hematology 113 (2), 273-278, 2009 | 474 | 2009 |
| ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death MT Vander Lugt, TM Braun, S Hanash, J Ritz, VT Ho, JH Antin, Q Zhang, ... New England Journal of Medicine 369 (6), 529-539, 2013 | 427 | 2013 |
| Immunobiology of acute graft-versus-host disease P Reddy, JLM Ferrara Blood reviews 17 (4), 187-194, 2003 | 371 | 2003 |
| Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease JLM Ferrara, AC Harris, JK Greenson, TM Braun, E Holler, T Teshima, ... Blood, The Journal of the American Society of Hematology 118 (25), 6702-6708, 2011 | 365 | 2011 |
| Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease UA Duffner, Y Maeda, KR Cooke, P Reddy, R Ordemann, C Liu, ... The Journal of Immunology 172 (12), 7393-7398, 2004 | 344 | 2004 |
| Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors KM Mustian, LK Sprod, M Janelsins, LJ Peppone, OG Palesh, ... Journal of Clinical Oncology 31 (26), 3233-3241, 2013 | 342 | 2013 |
| Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke DP Hopkins, PA Briss, CJ Ricard, CG Husten, VG Carande-Kulis, ... American journal of preventive medicine 20 (2), 16-66, 2001 | 338 | 2001 |
| Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect P Reddy, Y Maeda, K Hotary, C Liu, LL Reznikov, CA Dinarello, ... Proceedings of the National Academy of Sciences 101 (11), 3921-3926, 2004 | 331 | 2004 |
| Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial IR Kleckner, C Kamen, JS Gewandter, NA Mohile, CE Heckler, ... Supportive Care in Cancer 26, 1019-1028, 2018 | 329 | 2018 |
| Histone deacetylase inhibition modulates indoleamine 2, 3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in mice P Reddy, Y Sun, T Toubai, R Duran-Struuck, SG Clouthier, E Weisiger, ... The Journal of clinical investigation 118 (7), 2562-2573, 2008 | 323 | 2008 |
| A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA DL Barton, EJ Wos, R Qin, BI Mattar, NB Green, KS Lanier, JD Bearden, ... Supportive Care in Cancer 19, 833-841, 2011 | 300 | 2011 |
| A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses P Reddy, Y Maeda, C Liu, OI Krijanovski, R Korngold, JLM Ferrara Nature medicine 11 (11), 1244-1249, 2005 | 294 | 2005 |
John E. LevineMount Sinai School of MedicineVerified email at mssm.edu
